The scheme will benefit domestic manufacturers, spur job opportunities and contribute to availability of wider range of affordable medicines for consumers. It is expected to bring in investment of Rs 15,000 crore in the pharmaceutical sector, an official release said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3snThBD
via IFTTT
0 comments:
Post a Comment